News
December 13, 2024

IU announces $138 million Lilly Endowment grant, launches partnership to accelerate bioscience innovation

Regenstrief one of the partners expected to drive advancements and commercialization in biosciences 

Regenstrief Institute will partner with Indiana University and other key bioscience organizations in the state to make significant advances in human health and help make Indiana a global leader in bioscience innovation by establishing the IU Launch Accelerator for Biosciences, known as IU LAB, at the 16 Tech Innovation District in Indianapolis. 

“IU LAB will play a critical role in advancing life and biosciences innovation to address our state’s most critical health challenges,” said Rachel Patzer, PhD, MPH, Regenstrief president and CEO. Through its efforts to translate research into practice, this partnership will lead to better health outcomes and improved health care across Indiana.”  

View the complete press release on Indiana University’s webpage.  

Partners

Related News

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher

Rachel Patzer, PhD, MPH

Building trust in healthcare AI through data and evidence

As artificial intelligence rapidly transforms healthcare, innovation alone is not enough. Health systems need evidence that AI tools are

doctor using electronic health record

Data expertise helps researchers understand how clinical tools are used in real-world care

Regenstrief Data Services (RDS) provided critical health data and specialized expertise to support research examining clinical decision-support use across